6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02564 | CRAMP-18 E2K | GKKLKKIGQKIKNFFQKL | Synthetic | Disrupt cell membrane structure | MTT assay | K-562 | Chronic myelogenous Leukemia | IC50 : 20–34 uM |
| dbacp02565 | CRAMP-18 E2K | GKKLKKIGQKIKNFFQKL | Synthetic | Disrupt cell membrane structure | MTT assay | Jurkat | Acute T cell Leukemia | IC50 : 20–34 uM |
| dbacp02566 | CRAMP-18 E2K | GKKLKKIGQKIKNFFQKL | Synthetic | Disrupt cell membrane structure | MTT assay | K-549 | Acute T cell Leukemia | IC50 : 20–34 uM |
| dbacp02836 | Emericellipsin A | PQAAIVASG | **Emericellopsis alkaline** VKPM F1428, Alkalophile, extremophile | Disrupt cell membrane structures; Apoptosis | MTT assay | HeLa | Cervical cancer | EC50 : < 0.5 µM |
| dbacp02837 | Emericellipsin A | PQAAIVASG | **Emericellopsis alkaline** VKPM F1428, Alkalophile, extremophile | Disrupt cell membrane structures; Apoptosis | MTT assay | Hep G2 | Liver cancer | EC50 : 2.8 µM |
| dbacp04700 | MPC-A5K,A8K | LNLKKLLKVAKKIL | Amino acid substitution | Disrupt cell membrane structure | Not specified | Not found | Not found | Not found |